Growth Metrics

Kestra Medical Technologies (KMTS) Depreciation & Amortization (CF) (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $2.0 million as the latest value for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 5.03% to $2.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Jan 2026, down 14.68% year-over-year, with the annual reading at $8.0 million for FY2025, 31.07% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $2.0 million at Kestra Medical Technologies, down from $2.4 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $3.5 million in Q2 2024, with the low at $1.8 million in Q2 2025.
  • Average Depreciation & Amortization (CF) over 3 years is $2.4 million, with a median of $2.0 million recorded in 2025.
  • Peak annual rise in Depreciation & Amortization (CF) hit 26.97% in 2025, while the deepest fall reached 47.57% in 2025.
  • Over 3 years, Depreciation & Amortization (CF) stood at $1.9 million in 2024, then increased by 26.97% to $2.4 million in 2025, then decreased by 16.43% to $2.0 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $2.0 million, $2.4 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.